The Science and Art of De-risking Cancer Drug Development | Talking Precision Medicine #35
Talking Precision Medicine
by Genialis
1w ago
In this episode Genialis CEO Rafael Rosengarten sat down with Dr. Carolina Haefliger, head of translational medicine at Debiopharm, the privately held Swiss biopharma company focused on oncology drug development. They talked about de-risking promising new cancer drugs, and what it takes from the science to the team to the technologies. Episode 35 links: Visit ⁠⁠⁠TPM E35⁠⁠⁠ for highlights and links from this episode > Learn more about Genialis™ krasID > New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients > ..read more
Visit website
Professional grade software — a key ingredient in cutting edge biomedical discovery | Talking Precision Medicine #34
Talking Precision Medicine
by Genialis
4M ago
Today we turn the mic around, as our guest Adam Stasio hosts an excellent podcast of his own. Adam’s day job, however, is running SciMed, a boutique life sciences software development company. Adam and Genialis CEO Rafeal Rosengarten discuss the state of scientific software, the importance of agility and communication, and approaches to building a lasting company culture. Visit ⁠⁠TPM E34⁠⁠ for highlights and links from this episode ..read more
Visit website
New Medicines from Evolutionary Pathways: Using Comparative Genomics to Treat Human Disease | Talking Precision Medicine #33
Talking Precision Medicine
by Genialis
6M ago
Our guest today is Dr. Ashley Zehnder, co-founder and CEO of Fauna Bio. Fauna is a revolutionary young biotech company using comparative genomics of an array of non-traditional mammalian models to discover new therapeutic opportunities for people. What do ground squirrels have to do with treating battlefield trauma? Only one way to find out … Visit ⁠TPM E33⁠ for highlights and links from this episode ..read more
Visit website
To achieve personalized medicine, start by getting the dose right | Talking Precision Medicine #32
Talking Precision Medicine
by Genialis
9M ago
In this episode, Genialis CEO Rafael Rosengarten sits down with Ajay Gopal, CEO and founder of Rx Studio. Rx Studio is a technology company using data science to tackle a major limitation to personalized medicine: drug dosing. Visit TPM E32 for highlights and links from this episode ..read more
Visit website
AI and Ethics in Healthtech: Who is Innovating Most? | Talking Precision Medicine #31
Talking Precision Medicine
by Genialis
10M ago
In this episode, Genialis CEO Rafael Rosengarten speaks with BCG management consultant and healthcare innovation expert Amy MacDougall. They discuss emerging trends in healthcare, the role of AI, ethics and more, as well as BCG’s recently released 50 Most Innovative Companies List. Visit TPM E31 for highlights and links from this episode ..read more
Visit website
People first: building a company that inspires impactful work | Talking Precision Medicine #30
Talking Precision Medicine
by Genialis
11M ago
Our guest this episode is Dr. Susanna Harris, community lead at Vibe Bio. Susanna is a dedicated scientific communicator and an outspoken advocate for the mental health of PhD students and other science researchers. She has chronicled her journey from the academic lab bench to a venture incubator to a promising biotech company for a substantial social media following, and joins us today to dive into these topics and more. Come on in and have a listen. Visit TPM E30 for highlights and links from this episode ..read more
Visit website
Communication, the key to building community | Talking Precision Medicine #29
Talking Precision Medicine
by Genialis
11M ago
Welcome to Talking Precision Medicine — the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueling the next industrial revolution. Our guest this episode is Dr. Susanna Harris, community lead at Vibe Bio. Susanna is a dedicated scientific communicator and an outspoken advocate for the mental health of PhD students and other science researchers. She has chronicled her journey from the academic lab bench to a venture incubator to a promising biotech company for a substantial social media following, and joins us today to d ..read more
Visit website
A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28
Talking Precision Medicine
by Genialis
11M ago
Welcome to Talking Precision Medicine — the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueling the next industrial revolution. In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member. Come on in and ha ..read more
Visit website
What’s in a Name?: Endpoint Health’s Patient-Centric Northstar | Talking Precision Medicine #27
Talking Precision Medicine
by Genialis
11M ago
Welcome to Talking Precision Medicine — the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueling the next industrial revolution. This episode features Jason Springs, co-founder and CEO of Endpoint Health, an ascendant precision therapeutics company. Jason is a serial entrepreneur, who with the co-founders of his previous company, is building Endpoint Health to bring together under one roof the data science, diagnostics and therapeutics necessary to achieve truly personalized care. Come on in and have a listen. Visit h ..read more
Visit website
Taking charge of your health future with wearables and AI | Talking Precision Medicine #26
Talking Precision Medicine
by Genialis
11M ago
Welcome to Talking Precision Medicine — the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueling the next industrial revolution. In this episode 26, our host Rafael sits down with Harry Glorikian [pronounced Glor - ĭ - kian]. Harry is an investor, author, podcaster and veteran of the healthtech industry. Harry walks us through his latest book, The Future You, and expounds on the ways that wearable devices, personal health data and artificial intelligence are changing healthcare as we know it. Come on in and have a lis ..read more
Visit website

Follow Talking Precision Medicine on FeedSpot

Continue with Google
Continue with Apple
OR